Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 560,120 | 369,005 | 153,950 | -14,618 | 414,832 |
| Depreciation Amortization | 660,067 | 491,650 | 326,418 | 163,383 | 638,696 |
| Income taxes - deferred | -208,327 | -205,972 | -141,568 | -66,385 | -260,217 |
| Accounts receivable | -21,115 | -21,979 | 277 | -8,443 | -51,883 |
| Accounts payable and accrued liabilities | -20,073 | -16,938 | -4,148 | -19,597 | 9,603 |
| Other Working Capital | -76,720 | 3,212 | 29,594 | 56,400 | -204,439 |
| Other Operating Activity | 501,956 | 378,350 | 234,058 | 156,489 | 545,415 |
| Operating Cash Flow | $1,395,908 | $997,328 | $598,581 | $267,229 | $1,092,007 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -460,125 | -280,125 | -505,000 | -255,000 | -120,100 |
| PPE Investments | -38,070 | -24,783 | -13,995 | -6,904 | -23,962 |
| Purchase Sale Intangibles | -10,000 | -10,000 | -10,000 | -10,000 | -19,000 |
| Other Investing Activity | -10,000 | -10,000 | -10,000 | -10,000 | -19,000 |
| Investing Cash Flow | $-508,195 | $-314,908 | $-528,995 | $-271,904 | $-163,062 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 980,767 | 980,767 | N/A | N/A | N/A |
| Debt Repayment | -606,000 | -598,250 | -15,500 | -7,750 | -31,000 |
| Common Stock Issued | 20,647 | 11,451 | 11,434 | 494 | 46,459 |
| Common Stock Repurchased | -311,429 | -311,429 | -161,428 | N/A | -269,761 |
| Other Financing Activity | -63,469 | -53,748 | -52,143 | -49,296 | -50,952 |
| Financing Cash Flow | $20,516 | $28,791 | $-217,637 | $-56,552 | $-305,254 |
| Exchange Rate Effect | -1,675 | 614 | -2,457 | -1,698 | 1,137 |
| Beginning Cash Position | 1,506,310 | 1,506,310 | 1,506,310 | 1,506,310 | 881,482 |
| End Cash Position | 2,412,864 | 2,218,135 | 1,355,802 | 1,443,385 | 1,506,310 |
| Net Cash Flow | $906,554 | $711,825 | $-150,508 | $-62,925 | $624,828 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,395,908 | 997,328 | 598,581 | 267,229 | 1,092,007 |
| Capital Expenditure | -38,070 | -24,783 | -13,995 | -6,904 | -23,962 |
| Free Cash Flow | 1,357,838 | 972,545 | 584,586 | 260,325 | 1,068,045 |